Skip to content

Clinical trials

Terminated Phase 3 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 3 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20081
20132
20142
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
M.D. Anderson Cancer Center2
Chinese SLE Treatment And Research Group1
GlaxoSmithKline1
Hamilton Health Sciences Corporation1
McMaster University1
Novartis Pharmaceuticals1
Sobi, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia10
Hematologic Diseases3
Anemia2
Bone Marrow Diseases2
Myeloproliferative Disorders2
Polycythemia Vera2
Primary Myelofibrosis2
Splenomegaly2
Thrombocythemia, Essential2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.